{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T09:10:19Z","timestamp":1788772219438,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007212","name":"Region Vastra Gotaland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007212","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.genhosppsych.2026.07.010","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:23:24Z","timestamp":1785367404000},"page":"195-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Parenteral clomipramine in inpatient depression: a retrospective cohort study of treatment patterns and patient characteristics"],"prefix":"10.1016","volume":"102","author":[{"given":"Michael","family":"Ioannou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ane Bakken","family":"Wold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Karan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Poth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazi","family":"Ladjemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yar","family":"Nuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria Paraskevi","family":"Daniilidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6rjan","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steinn","family":"Steingrimsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0005","article-title":"Psychiatric inpatient bed capacity and suicide mortality in Sweden: a nationwide ecological study","volume":"66","author":"Berge","year":"2026","journal-title":"Lancet Reg Health - Eur"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0010","series-title":"Man. Inpatient psychiatry","first-page":"28","article-title":"The inpatient with depression","author":"Drake","year":"2020"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0015","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jad.2019.08.064","article-title":"Less memory complaints with reduced stimulus dose during electroconvulsive therapy for depression","volume":"259","author":"Kronsell","year":"2019","journal-title":"J Affect Disord"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0020","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2023.5","article-title":"Response to electroconvulsive therapy in treatment-resistant depression: nationwide observational follow-up study","volume":"9","author":"Nygren","year":"2023","journal-title":"BJPsych Open"},{"issue":"3","key":"10.1016\/j.genhosppsych.2026.07.010_bb0025","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2020.17","article-title":"Cognitive side-effects of electroconvulsive therapy: what are they, how to monitor them and what to tell patients","volume":"6","author":"Porter","year":"2020","journal-title":"BJPsych Open."},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0030","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/ijnp\/pyab088","article-title":"Racemic ketamine as an alternative to electroconvulsive therapy for unipolar depression: a randomized, open-label, non-inferiority trial (KetECT)","volume":"25","author":"Ekstrand","year":"2022","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0035","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1001\/jamapsychiatry.2025.3019","article-title":"Serial ketamine infusions as adjunctive therapy to inpatient Care for Depression: the KARMA-dep 2 randomized clinical trial","volume":"82","author":"Jelovac","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0040","article-title":"Repeated intravenous infusions of esketamine in inpatients with bipolar depression: a retrospective real-world study","volume":"19","author":"Shire","year":"2025","journal-title":"J Affect Disord Rep"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0045","unstructured":"Kielholz P. Treatment of drug-resistant depression by intravenous administration of antidepressants. Zh Nevropatol Psikhiatr Im S S Korsakova 1952 1990;90:53\u20136."},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0050","article-title":"A new adjunct to the treatment and management of depression: intravenous infusion of chlorimipramine (anafranil)","volume":"45","author":"Becker","year":"1971","journal-title":"S Afr Med J"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0055","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/030006057300100519","article-title":"A Clomipramine (Anafranil) Infusion Unit","volume":"1","author":"O\u2019Flanagan","year":"1973","journal-title":"J Int Med Res"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0060","first-page":"857","article-title":"Preliminary results of the use of chlorimipramine administered by drip phleboclysis in therapy of depressive states","volume":"94","author":"Campailla","year":"1966","journal-title":"G Psichiatr Neuropatol"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0163-8343(80)90109-7","article-title":"Intravenous chlorimipramine and refractory depression","volume":"2","author":"Dudley","year":"1980","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0070","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2165\/00003088-199120060-00002","article-title":"Clinical pharmacokinetics of clomipramine","volume":"20","author":"Balant-Gorgia","year":"1991","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0075","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0364-7722(80)90050-8","article-title":"The bioavailability of oral and parenteral chlorimipramine (Anafranil)","volume":"4","author":"Evans","year":"1980","journal-title":"Prog Neuropsychopharmacol"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0080","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-2006-946701","article-title":"The complexity of active metabolites in therapeutic drug monitoring of psychotropic drugs","volume":"39","author":"Hendset","year":"2006","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0085","series-title":"Efficacy and safety of parenteral clomipramine compared to oral clomipramine or other treatments for depression or obsessive-compulsive disorder","author":"Ioannou","year":"2025"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0090","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/030006057300100513","article-title":"Clomipramine (Anafranil), Tofranil (imipramine) and placebo: a comparative study in relation to electroconvulsive therapy","volume":"1","author":"Gore","year":"1973","journal-title":"J Int Med Res"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0095","doi-asserted-by":"crossref","unstructured":"Kielholz P, Terzani S, Gastpar M, Adams C. Management of treatment-resistant depression without ECT (author's transl). Dtsch Med Wochenschr 1946 1981;106:671\u20133. doi:https:\/\/doi.org\/10.1055\/s-2008-1070377.","DOI":"10.1055\/s-2008-1070377"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0100","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4321\/S0213-61632007000400003","article-title":"Pulse intravenous clomipramine as an alternative antidepressant treatment to ECT: a pilot study","volume":"21","author":"Persson","year":"2007","journal-title":"Eur J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0105","first-page":"1","article-title":"Parenteral clomipramine for depression or obsessive-compulsive disorder: a systematic review and meta-analysis","author":"Ioannou","year":"2026","journal-title":"Acta Neuropsychiatr"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0110","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1056\/NEJMoa2302399","article-title":"Ketamine versus ECT for nonpsychotic treatment-resistant major depression","volume":"388","author":"Anand","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.genhosppsych.2026.07.010_b9000","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLOS Med"},{"key":"10.1016\/j.genhosppsych.2026.07.010_b9005","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0120","first-page":"68","article-title":"Infection control--a battle in vein: infusion phlebitis","volume":"94","author":"Jackson","year":"1998","journal-title":"Nurs Times"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00124509-200309000-00005","article-title":"A Meta-analysis of electroconvulsive therapy efficacy in depression","volume":"19","author":"Kho","year":"2003","journal-title":"J ECT"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00124509-200403000-00004","article-title":"Efficacy of ECT in depression: a Meta-analytic review","volume":"20","author":"Pagnin","year":"2004","journal-title":"J ECT"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0135","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(03)12705-5","article-title":"Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis","volume":"361","author":"The UK ECT Review Group","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0140","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.euroneuro.2024.09.002","article-title":"A higher desmethylclomipramine to clomipramine ratio predicts more effectiveness and fewer adverse effects in major depressive disorder","volume":"89","author":"Vos","year":"2024","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"issue":"Suppl. 1","key":"10.1016\/j.genhosppsych.2026.07.010_bb0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1520-6394(1998)7:1+<11::AID-DA4>3.0.CO;2-I","article-title":"SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability","volume":"7","author":"Anderson","year":"1998","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0150","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/5448587","article-title":"Use of antidepressant and anxiolytic drugs in Scandinavian countries between 2006 and 2021: a prescription database study","author":"Bojani\u0107","year":"2024","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0155","doi-asserted-by":"crossref","first-page":"330","DOI":"10.5498\/wjp.v5.i3.330","article-title":"Pharmacologic approaches to treatment resistant depression: evidences and personal experience","volume":"5","author":"Tundo","year":"2015","journal-title":"World J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0160","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/s12888-021-03490-x","article-title":"Tricyclic antidepressants for major depressive disorder: a comprehensive evaluation of current practice in the Netherlands","volume":"21","author":"Vos","year":"2021","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0165","article-title":"Changes in psychiatric inpatient service utilization during the first and second waves of the COVID-19 pandemic","volume":"13","author":"Hamlin","year":"2022","journal-title":"Front Psychol"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0170","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.genhosppsych.2023.11.007","article-title":"The impact of COVID-19 three years on: introduction to the 2023 special issue","volume":"86","author":"Maunder","year":"2024","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0175","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0924-977X(97)00048-5","article-title":"Pulse loading versus gradual dosing of intravenous clomipramine in obsessive-compulsive disorder","volume":"8","author":"Koran","year":"1998","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0180","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0185","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bjp.0707253","article-title":"Tricyclic antidepressant pharmacology and therapeutic drug interactions updated","volume":"151","author":"Gillman","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0190","series-title":"Clomipramine","author":"Wilson","year":"2023"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0195","article-title":"Clinical-epidemiological predictors of phlebitis associated with peripheral intravenous catheters in Spanish hospitals: results of a national cohort study","volume":"9","author":"Cernuda-Mart\u00ednez","year":"2025","journal-title":"Int J Nurs Stud"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0200","doi-asserted-by":"crossref","first-page":"e424","DOI":"10.1016\/S2352-3026(17)30122-9","article-title":"Measurement of peripheral venous catheter-related phlebitis: a cross-sectional study","volume":"4","author":"G\u00f6ransson","year":"2017","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0205","doi-asserted-by":"crossref","DOI":"10.4045\/tidsskr.19.0653","article-title":"Use of peripheral venous catheters in two Norwegian hospitals","author":"H\u00f8vik","year":"2020","journal-title":"Tidsskr Den Nor Legeforen"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0210","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-029514","article-title":"Ethnographic study using normalization process theory to understand the implementation process of infection prevention and control guidelines in Ireland","volume":"9","author":"Agreli","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0215","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-244X-10-8","article-title":"Implementing clinical guidelines in psychiatry: a qualitative study of perceived facilitators and barriers","volume":"10","author":"Forsner","year":"2010","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0220","doi-asserted-by":"crossref","DOI":"10.2196\/10769","article-title":"Exploring how evidence is used in care through an organizational ethnography of two teaching hospitals","volume":"21","author":"Lander","year":"2019","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2019.112731","article-title":"Translating healthcare research evidence into practice: the role of linked boundary objects","volume":"246","author":"Melo","year":"2020","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0230","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0278-5846(01)00250-0","article-title":"A survey of prescribing practices in the treatment of depression","volume":"26","author":"Petersen","year":"2002","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0235","doi-asserted-by":"crossref","DOI":"10.2196\/49781","article-title":"Case identification of depression in inpatient electronic medical records: scoping review","volume":"12","author":"Grothman","year":"2024","journal-title":"JMIR Med Inform"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0240","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.npbr.2020.02.002","article-title":"Defining major depressive disorder cohorts using the EHR: multiple phenotypes based on ICD-9 codes and medication orders","volume":"36","author":"Ingram","year":"2020","journal-title":"Neurol Psychiatry Brain Res"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0245","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.genhosppsych.2026.04.001","article-title":"Continuation of newly initiated antipsychotics at hospital discharge in older medical inpatients: a retrospective cohort study","volume":"100","author":"Yamamoto","year":"2026","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0250","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/wps.70013","article-title":"Representation and outcomes of individuals with major depression in routine care who are ineligible for randomized controlled trials: a nationwide register-based study","volume":"25","author":"Hamina","year":"2026","journal-title":"World Psychiatry"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0255","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4997\/jrcpe.2020.409","article-title":"Retrospective studies - utility and caveats","volume":"50","author":"Talari","year":"2020","journal-title":"J R Coll Physicians Edinb"},{"key":"10.1016\/j.genhosppsych.2026.07.010_bb0260","doi-asserted-by":"crossref","DOI":"10.3352\/jeehp.2013.10.12","article-title":"The retrospective chart review: important methodological considerations","volume":"10","author":"Vassar","year":"2013","journal-title":"J Educ Eval Health Prof"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834326001611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834326001611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T08:40:20Z","timestamp":1788770420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834326001611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":53,"alternative-id":["S0163834326001611"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2026.07.010","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parenteral clomipramine in inpatient depression: a retrospective cohort study of treatment patterns and patient characteristics","name":"articletitle","label":"Article Title"},{"value":"General Hospital Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2026.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}